122 related articles for article (PubMed ID: 6418330)
1. Striatal dopamine metabolism in living monkeys examined by positron emission tomography.
Garnett S; Firnau G; Nahmias C; Chirakal R
Brain Res; 1983 Nov; 280(1):169-71. PubMed ID: 6418330
[TBL] [Abstract][Full Text] [Related]
2. Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate.
Firnau G; Sood S; Chirakal R; Nahmias C; Garnett ES
J Neurochem; 1987 Apr; 48(4):1077-82. PubMed ID: 3102690
[TBL] [Abstract][Full Text] [Related]
3. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
Doudet DJ; Chan GL; Holden JE; McGeer EG; Aigner TA; Wyatt RJ; Ruth TJ
Synapse; 1998 Jul; 29(3):225-32. PubMed ID: 9635892
[TBL] [Abstract][Full Text] [Related]
4. Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa.
Guttman M; Léger G; Reches A; Evans A; Kuwabara H; Cedarbaum JM; Gjedde A
Mov Disord; 1993 Jul; 8(3):298-304. PubMed ID: 8341294
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine.
Doudet DJ; Chan GL; Jivan S; DeJesus OT; McGeer EG; English C; Ruth TJ; Holden JE
J Cereb Blood Flow Metab; 1999 Mar; 19(3):278-87. PubMed ID: 10078880
[TBL] [Abstract][Full Text] [Related]
6. 6-18F-L-dopa imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys.
Doudet DJ; Miyake H; Finn RT; McLellan CA; Aigner TG; Wan RQ; Adams HR; Cohen RM
Exp Brain Res; 1989; 78(1):69-80. PubMed ID: 2512179
[TBL] [Abstract][Full Text] [Related]
7. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine.
Tabbal SD; Mink JW; Antenor JA; Carl JL; Moerlein SM; Perlmutter JS
Neuroscience; 2006 Sep; 141(3):1281-7. PubMed ID: 16766129
[TBL] [Abstract][Full Text] [Related]
8. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
[TBL] [Abstract][Full Text] [Related]
9. The reproducibility of striatal uptake data obtained with positron emission tomography and fluorine-18-L-6-fluorodopa tracer in non-human primates.
Pate BD; Snow BJ; Hewitt KA; Morrison KS; Ruth TJ; Calne DB
J Nucl Med; 1991 Jun; 32(6):1246-51. PubMed ID: 1904482
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
Kanazawa M; Ohba H; Harada N; Kakiuchi T; Muramatsu S; Tsukada H
J Nucl Med; 2016 Feb; 57(2):303-8. PubMed ID: 26564319
[TBL] [Abstract][Full Text] [Related]
11. Striatal glucose metabolism and [18F]fluorodopa uptake in a patient with tumor-induced hemiparkinsonism.
Miyagi Y; Morioka T; Otsuka M; Fukui M
Neurosurgery; 1993 May; 32(5):838-41. PubMed ID: 8492861
[TBL] [Abstract][Full Text] [Related]
12. Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice.
Honer M; Hengerer B; Blagoev M; Hintermann S; Waldmeier P; Schubiger PA; Ametamey SM
Nucl Med Biol; 2006 Jul; 33(5):607-14. PubMed ID: 16843835
[TBL] [Abstract][Full Text] [Related]
13. Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys.
Guttman M; Yong VW; Kim SU; Calne DB; Martin WR; Adam MJ; Ruth TJ
Synapse; 1988; 2(5):469-73. PubMed ID: 3263709
[TBL] [Abstract][Full Text] [Related]
14. Determination and visualization of damage to striatal dopaminergic terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by [18F]-labeled 6-fluoro-L-dopa and positron emission tomography.
Chiueh CC; Firnau G; Burns RS; Nahmias C; Chirakal R; Kopin IJ; Garnett ES
Adv Neurol; 1987; 45():167-9. PubMed ID: 3103385
[No Abstract] [Full Text] [Related]
15. 6-[18F]fluoro-L-dopa and cerebral blood flow in unilaterally MPTP-treated monkeys.
Doudet DJ; Wyatt RJ; Cannon-Spoor E; Suddath R; McLellan CA; Cohen RM
J Neural Transplant Plast; 1993; 4(1):27-38. PubMed ID: 7509198
[TBL] [Abstract][Full Text] [Related]
16. Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.
Sawle GV; Playford ED; Brooks DJ; Quinn N; Frackowiak RS
Brain; 1993 Aug; 116 ( Pt 4)():853-67. PubMed ID: 8353712
[TBL] [Abstract][Full Text] [Related]
17. Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.
Brück A; Aalto S; Nurmi E; Vahlberg T; Bergman J; Rinne JO
Mov Disord; 2006 Jul; 21(7):958-63. PubMed ID: 16550545
[TBL] [Abstract][Full Text] [Related]
18. Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography.
Grant KA; Shively CA; Nader MA; Ehrenkaufer RL; Line SW; Morton TE; Gage HD; Mach RH
Synapse; 1998 May; 29(1):80-3. PubMed ID: 9552177
[No Abstract] [Full Text] [Related]
19. 6-[18F]fluoro-L-dopa metabolism in MPTP-treated monkeys: assessment of tracer methodologies for positron emission tomography.
Melega WP; Hoffman JM; Schneider JS; Phelps ME; Barrio JR
Brain Res; 1991 Mar; 543(2):271-6. PubMed ID: 1905578
[TBL] [Abstract][Full Text] [Related]
20. Striatal dopamine during sensorial stimulations: a [18F]FDOPA PET study in human and cats.
Hassoun W; Thobois S; Ginovart N; Garcia-Larrea L; Cavorsin ML; Guillouet S; Bonnefoi F; Costes N; Lavenne F; Martin JP; Broussolle E; Leviel V
Neurosci Lett; 2005 Jul 22-29; 383(1-2):63-7. PubMed ID: 15936513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
